Tissue tropism of SV40 transformation of human cells: Role of the viral regulatory region and of cellular oncogenes

Genes and Cancer

Volumn 1, Issue 10, 2010, Pages 1008-1020

  Zhang, Lei ^a,b   Qi, Fang ^a,c   Gaudino, Giovanni ^a   Strianese, Oriana ^a   Yang, Haining ^a,b   Morris, Paul ^d   Pass, Harvey I ^e   Nerurkar, Vivek R ^b   Bocchetta, Maurizio ^f   Carbone, Michele ^a,b  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d QUEEN S MEDICAL CENTER   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

72 Bp elements; Astrocytes; Mesothelial cells; Notch 1; SV40

Indexed keywords

MYC PROTEIN; NOTCH1 RECEPTOR; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR HES 1;

ARTICLE; ASTROCYTE; BRAIN TUMOR; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MESOTHELIOMA; MESOTHELIUM CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; VIRAL TROPISM; VIRUS MORPHOLOGY; VIRUS REGULATORY REGION; VIRUS STRAIN;

CRICETINAE;

EID: 79952847461     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601910395580     Document Type: Article

References (41)

1. Sweet BH, Hilleman MR. The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med. 1960;105:420-7.
2. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst. 1999;91(2):119-34.
3. Cutrone R, Lednicky J, Dunn G, et al. Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res. 2005;65(22):10273-9.
4. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol. 1993;142(5):1524-33.
5. Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer. 2002;2(12):957-64.
6. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog. 2009;5(3):e1000363.
7. Comar M, Rizzardi C, de Zotti R, et al. SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. Cancer Res. 2007;67(18):8456-9.
8. Carbone M, Albelda SM, Broaddus VC, et al. Eighth international mesothelioma interest group. Oncogene. 2007;26(49):6959-67.
9. Heinsohn S, Szendroi M, Bielack S, Stadt UZ, Kabisch H. Evaluation of SV40 in osteosarcoma and healthy population: a Hungarian- German study. Oncol Rep. 2009;21(2):289-97.
10. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet. 2002;359(9309):851-2.
11. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet. 2002;359(9309):817-23.
12. Capello D, Rossi D, Gaudino G, Carbone A, Gaidano G. Simian virus 40 infection in lymphoproliferative disorders. Lancet. 2003;361(9351): 88-9.
13. Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene. 2001;20(33):4441-9.
14. Mendoza SM, Konishi T, Miller CW. Integration of SV40 in human osteosarcoma DNA. Oncogene. 1998;17(19):2457-62.
15. Yamamoto H, Nakayama T, Murakami H, et al. High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br J Cancer. 2000;82(10):1677-81.
16. Carbone M, Rizzo P, Grimley PM, et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med. 1997;3(8): 908-12.
17. Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L, Carbone M. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res. 2008;68(4):1022-9.
18. Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene. 2003;22(1):81-9.
19. Cacciotti P, Libener R, Betta P, et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A. 2001;98(21):12032-7.
20. D'Alisa RM, Gershey EL. On the quantitation of SV40 virus by plaque assay and immunoperoxidase technique. J Histochem Cytochem. 1978;26(9):755-8.
21. Carbone M, Klein G, Gruber J, Wong M. Modern criteria to establish human cancer etiology. Cancer Res. 2004;64(15):5518-24.
22. Fahrbach KM, Katzman RB, Rundell K. Role of SV40 ST antigen in the persistent infection of mesothelial cells. Virology. 2008;370(2):255-63.
23. Carbone M, Pannuti A, Zhang L, Testa JR, Bocchetta M. A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells. Cancer Res. 2008;68(22):9488-96.
24. Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol. 2001;11(1):31-8.
25. Das GC, Niyogi SK, Salzman NP. SV40 promoters and their regulation. Prog Nucleic Acid Res Mol Biol. 1985;32:217-36.
26. Graziani I, Eliasz S, De Marco MA, et al. Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway. Cancer Res. 2008;68(23):9678-85.
27. Sangar D, Pipkin PA, Wood DJ, Minor PD. Examination of poliovirus vaccine preparations for SV40 sequences. Biologicals. 1999;27(1): 1-10.
28. Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, Miele L. Rational targeting of Notch signaling in cancer. Oncogene. 2008;27(38): 5124-31.
29. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature. 2005;435(7042): 682-6.
30. Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14(6):453-71.
31. Morike M, Quaiser A, Muller D, Montenarh M. Early gene expression and cellular DNA synthesis after stimulation of quiescent NIH3T3 cells with serum or purified simian virus 40. Oncogene. 1988;3(2):151-8.
32. Cacciotti P, Barbone D, Porta C, et al. SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. Cancer Res. 2005;65(12):5256-62.
33. Gutierrez A, Look AT. NOTCH and PI3K-AKT pathways intertwined. Cancer Cell. 2007;12(5):411-3.
34. Kanamori M, Kawaguchi T, Nigro JM, et al. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg. 2007;106(3):417-27.
35. Stella MC, Trusolino L, Pennacchietti S, Comoglio PM. Negative feedback regulation of Met-dependent invasive growth by Notch. Mol Cell Biol. 2005;25(10):3982-96.
36. Li H, Chang YW, Mohan K, et al. Activated Notch1 maintains the phenotype of radial glial cells and promotes their adhesion to laminin by upregulating nidogen. Glia. 2008;56(6):646-58.
37. Li Y, Rao PK, Wen R, et al. Notch and Schwann cell transformation. Oncogene. 2004;23(5):1146-52.
38. Lednicky JA, Wong C, Butel JS. Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776. Virus Res. 1995;35(2):143-53.
39. Lednicky JA, Butel JS. Tissue culture adaptation of natural isolates of simian virus 40: changes occur in viral regulatory region but not in carboxy-terminal domain of large T-antigen. J Gen Virol. 1997;78(Pt 7):1697-705.
40. Fukazawa H, Mizuno S, Uehara Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal Biochem. 1995;228(1):83-90.
41. Chen Y, De Marco MA, Graziani I, et al. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res. 2007;67(17):7954-9.